Anthelmintic Formulations and Treatments
AssigneeVirbac
InventorsNicola Jane Cuff, Peter Norman Pulford, Mark Colin Vickers
Life of this patent
Estimating the term…
Loading patent…
AssigneeVirbac
InventorsNicola Jane Cuff, Peter Norman Pulford, Mark Colin Vickers
Estimating the term…
A new method of controlling worm burden in ruminants by using two different injectable anthelmintics at or about the same time to increase the time between treatments and to rely on the animal's immune response. One of the anthelmintics is a long acting formulation capable of providing a sustained release of abamectin or other macrocyclic lactone for 2-14 days, to enable the anthelmintic to remove or kill incoming larvae for a sufficiently long period of time to allow the host to recognise the incoming larvae as foreign, and thus allow the ruminant to mount an immune response against these incoming larvae. The other is a short acting anthelmintic such as levamisole designed to substantially eliminate the initial parasite population of adults, juveniles and larvae. They can be combined into a single injectable formulation with a high percentage of levamisole (preferably over 30% of the formulation w/v) together with about 1% w/v of a macrocyclic lactone such as abamectin, dissolved in glycerol formal.
A veterinary composition or compositions comprising an amount of levamisole and one or more macrocyclic lactones (MLs) effective for the treatment of a young ruminant animal at intervals of 40 to 60 days.
A method of controlling internal parasites in ruminants and extending the time between treatments to minimize drench use, comprising treating the animal with an amount of levamisole effective to substantially eliminate the initial adult and immature parasite population present in the animal, and at substantially the same time treating the animal with an amount of macrocyclic lactones (ML) that acts for a duration of a minimum of about 3 to 5 days or more to re-program the animal's immune system to recognise incoming larvae as foreign and mount a self-treatment/immune response to the incoming larvae.
A method of controlling parasites in ruminants by treating a ruminant animal with at least (a) a long acting oral or injectable or implantable anthelmintic formulation A capable of removing or killing incoming larvae for a sufficiently long period to allow the host to recognise incoming larvae as foreign and mount an immune response/self-treatment effect to reduce the effect of the parasite including reduce egg output and incoming larvae, and (b) treating the ruminant with a short acting oral or injectable anthelmintic formulation B to substantially eliminate the initial parasite population.
An anthelmintic formulation comprising a long acting anthelmintic A together with a short acting anthelmintic B, wherein anthelmintic A is capable of a persistent activity over a period of 3 to 14 days, and wherein the short acting anthelmintic B is capable of peaking within 1-8 hours of administration and is designed to be substantially eliminated from the animal within 24-48 hours of treatment.
An injectable veterinary formulation comprising (A) a macrocyclic lactone in the range from 0.5% to 2% w/v, and (B) levamisole in the range from 5% to 60% w/v, dissolved in a non-aqueous solvent system.
Dependencies are inferred from the claim text.